Biliary Dilatation National Special Disease Cohort in China
ConditionCholedochal Cyst
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 80
SponsorBeijing Tsinghua Chang Gung Hospital
About this trial
This study is a multicenter, bidirectional cohort study aimed at continuously enrolling patients with biliary dilatation from 25 medical centers in China. It will collect comprehensive life-cycle data from the cohort to establish a Chinese cohort for bile duct dilatation. Based on this cohort, the study seeks to clarify the epidemiological characteristics, pathological features, standard classification, disease progression, cancer risk, and optimal timing for surgical intervention in patients with bile duct dilatation. Additionally, it will compare the perioperative risks, long-term outcomes, and quality of life among different types of patients (including Todani types I, IVa, and V) following surgical treatment, to establish standardized surgical treatment strategies for each type.
Eligibility criteria
Qualifiers
Patients who have been definitive diagnosed with biliary dilation.
Patients aged between 0 and 80 years old, regardless of gender.
In line with the principle of informed consent: For the retrospective cohort of biliary dilation, exemption from signing the informed consent form is applied for, while for the prospective cohort, signing the informed consent form is required.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
6,000 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov